Behcets Syndrome
NEJM 390:640-651, Saadoun,D.,et al, 2024
Clinicopathologic Conference, Antiphospholipid Syndrome due to SLE with Hypocomplimentemia
NEJM 389: 2277-2285, Case 38-2023, 2023
Diagnosis and Management of the Antiphospholipid Syndrome
NEJM 378:2010-2021, Garcia, D. & Erkan, D., 2018
Behcet Disease
emedicine.medscape.com Dec, Davey-Ranasinghe, N. & Diamond, H.S., 2018
Venous Thrombotic Recurrence after Cerebral Venous Thrombosis
Stroke 48:321-326, Palazzo, P.,et al, 2017
Is Prophylactic Anticoagulation for Deep Venous Thrombosis Common Practice after Intracerebral Hemorrhage?
Stroke 46:369-375, Prabhakaran, S.,et al, 2015
A 50-year-old Man with "Elephantiasis" and Headache
Neurol 85:e52-e55, Yaghi, S.,et al, 2015
Diagnostic Yield of Pelvic Magnetic Resonance Venography in Patients with Cryptogenic Stroke and Patent Foramen Ovale
Stroke 45:2324-2329, Liberman, A.L.,et al, 2014
Management of Antithrombotic Therapy in Patients Undergoing Invasive Procedures
NEJM 368:2113-2124, Baron, T.,et al, 2013
Trousseaus Syndrome Due to Asymptomatic Pancreatic Adenocarcinoma
GE J Port Gastroenterol 20:172-176, Murinello, A.,et al, 2013
Post-acute care and secondary prevention after ischaemic stroke
BMJ 342:d2083, McArthur, K.S.,et al, 2011
Medical Complications Among Hospitalizations for Ischemic Stroke in the United States from 1998 to 2007
Stroke 41:980-986, Tong,X., et al, 2010
Diagnosis and Management of the Antiphospholipid Syndrome
BMJ 340:1125-1132, Cohen,D., et al, 2010
Transverse Myelitis
NEJM 363:564-572, Frohman,E.M. &Wingerchuk,D.M., 2010
Effectiveness of Thigh-Length Graduated Compression Stockings to Reduce the Risk of Deep Vein Thrombosis After Stroke (CLOTS Trial 1): A Multicentre, Randomised Controlled Trial
Lancet 373:1958-1965,1923, The CLOTS Trial Collaboration, 2009
May-Thurner Syndrome in Patients with Cryptogenic Stroke and Patent Foramen Ovale
Stroke 40:1502-1504, Kiernan, T.J.,et al, 2009
Venous and arterial thrombo-embolic complications of hormonal treatment in a male-to-female transgender patient
J Clin Neurosci 15:714-716, Mullins, G.M.,et al, 2008
The Efficacy and Safety of Enoxaparin Versus Unfractionated Heparin for the Prevention of Venous Thromboembolism After Acute Ischaemic Stroke (PREVAIL Study): An Open-Label Randomised Comparison
Lancet 369:1347-1355, Sherman,D.G.,et al, 2007
Thromboembolic Adverse Events After Use of Recombinant Human Coagulation Factor VIIa
JAMA 295:293-298, OConnell,K.A.,et al, 2006
Management of Antiphospholipid Antibody Syndrome, A Systematic Review
JAMA 295:1050-1057, Lim,W.,et al, 2006
Ischaemic Stroke With Malignancy May Often Be Caused by Paradoxical Embolism
JNNP 77:1336-1339, Iguchi,Y.,et al, 2006
Prevention of Venous Thrombosis in Patrients with Acute Intracerebral Hemorrhage
Neurol 65:865-869, Lacut,K.,et al, 2005
Increased Pelvic Vein Thrombi in Cryptogenic Stroke
Stroke 35:46-50, Cramer,S.C.,et al, 2004
Effective Prophylaxis for Deep Vein Thrombosis After Stroke, Low-Dose Anticoagulation Rather Than Stockings Alone: Against
Stroke 35:2912-2913,2910, Dennis,M.S., 2004
Effective Prophylaxis for Deep Vein Thrombosis After Stroke, Low-Dose Angicoagulation Rather Than Stockings Alone: For
Stroke 35:2911-2912,2910, Adams,H.P., 2004
Anticoagulation or Inferior Vena Cava Filter Placement for Patients with Primary Intracerebral Hemorrhage Developing Venous Thromboembolism?
Stroke 34:2999-3005, Kelly,J.,et al, 2003
"Economy Class" Stroke Syndrome?
Neurol 58:960-961, Isayev,Y.,et al, 2002
Low-Molecular-Weight Heparins or Heparinoids Versus Standard Unfarctionated Heparin for Acute Ischemic Stroke (Cochrane Review)
Stroke 33:1925-1926, Counsell,C. &Sandercock,P., 2002
Venous Thromboembolism After Acute Stroke
Stroke 32:262-267, Kelly,J.,et al, 2001
Cerebral Venous Thrombosis:Role of Activated Protein C Resistance and Factor V Gene Mutation
Stroke 27:1719-1720, Brey,R.L.&Coull,B.M., 1996
Medical Complications During Stroke Rehabilitation
Stroke 26:990-994, Kalra,L.,et al, 1995
Ischemic Stroke in Young Pts with Activated Protein C Resistance:Rpt of Three Cases Belonging to Three Different Kindreds
Stroke 26:885-890, Simioni,P.,et al, 1995
Transesophageal Echocardiography & Contrast-TCD in the Detection of a Patent Foramen Ovale:Experiences with 111 Pts
Neurol 44:1603-1606, Klotzsch,C.,et al, 1994
The Prevalence of Deep Venous Thrombosis in Patients with Suspected Paradoxical Embolism
Ann Int Med 119:461-465, Stollberger,C.,et al, 1993
Venous Thromboembolism in Acute Stroke, Prognostic Importance of Hypercoagulability
Arch Neurol 49:279-283, Landi,G.,et al, 1992
Complications of Acute Stroke
Lancet 339:721-724, Oppenheimer,S.&Hachinski,V., 1992
Venous Thromboembolism in Stroke:Literature Review and Implications for Clinical Practice
Arch Phys Med Rehabil 73:379-391, Brandstater,M.E.,et al, 1992
Early Heparin Therapy in Patients with Spontaneous Intracerebral Haemorrhage
JNNP 54:466-467, Boeer,A.,et al, 1991
Atrial Fibrillation as a Risk Factor for Deep Venous Thrombosis and Pulmonary Emboli in Stroke Patients
Stroke 22:760-762, Noel,P.,et al, 1991
Acute Cerebrovascular Episodes in Systemic Lupus Erythematosus
Quart J Med 293:739-750, Eustace,S.,et al, 1991
The Evolution of Oral Contraceptives Maximizing Efficacy, Minimizing Risks
Acta Obstet Gynecol Scand (Suppl) 152:7-12990., Hedon,B., 1990
Prevalence of Patent Foramen Ovale in Patients with Stroke
NEJM 318:1148-1152, 11971988., Lechat,P.,et al, 1988
Ischemic Stroke Associated with Anticardiolipin Antibodies
Stroke 18:1101-1106, Levine,S.R.,et al, 1987
Cerebral Haemorrhagic Infarction in Young Patients with Hereditary Protein C Deficiency
BMJ 290:350-352, Wintzen,A.R.,et al, 1985
Cerebral Emboli of Paradoxical Origin
Ann Neurol 13:314-319, Jones,H.R.,et al, 1983
Nonbacterial Thrombotic Endocarditis
Arch Neurol 39:95-98, Biller,J.,et al, 1982
Superior Sagittal Sinus Thrombosis
Arch Neurol 34:2, Gettelfinger,D.M.,et al, 1977
Neuro-Behcet Disease:Two Cases & Neuroradiologic Findings
Neurol 27:1148, Kozin,F.,et al, 1977
Cerebral Embolism Caused by Nonbacterial Thrombotic Endocarditis
Neurol 10:391, Barron,K.D.,et al, 1960